Sign In
Free Newsletter
Trump’s pause on $3T in federal funding could impact Va.
Update, 7:30 p.m. A federal judge temporarily blocked President Donald Trump‘s freeze on federal spending until at least Feb. 3, but the White House did not immediately respond to the judicial order. On Monday, Trump ordered a freeze on more than $3 trillion in federal financial assistance, including grants and loans backing economic development and […]
Building support
Gov. Glenn Youngkin made headlines last December when he announced a $90 million-plus pitch to launch “Virginia’s Research Triangle.” Initially envisioned as a cooperative initiative among Virginia Commonwealth University, Virginia Tech and the University of Virginia, the triangle was expanded into more of a rhombus following the addition of Old Dominion University to the research [&hell[...]
VCU launches pharmaceutical sciences undergrad degree
Graduate school isn’t a prerequisite for a career in the pharmaceutical industry. Virginia Commonwealth University’s new Bachelor of Science in Pharmaceutical Sciences (BSPS) degree will prepare students to step into pharma jobs like quality assurance technicians, research technologists and laboratory technicians, according to Kelechi “K.C.” Ogbonna, dean of VCU’s S[...]
Health Care 2023: DR. ERIC EDWARDS
In May 2020, just four months after Edwards co-founded Phlow, the Trump administration awarded the company $354 million to create a domestic supply chain for essential drugs and pharmaceutical ingredients in short supply. Phlow says it’s on track to meet the contract’s deliverables by its May 2024 expiration and hopes to land an $812 million, […]
Phlow promotes chief biz officer to president
Richmond-based Phlow Corp. has promoted Dan Hackman from chief business officer to president, the pharmaceutical manufacturing company announced Thursday. Hackman joined Phlow in 2020. He previously worked with Kaleo Inc. as general manager of its Auvi-Q product — an injectable pen developed for emergency allergy treatment — and served as its vice president of patient […]
Two Va. projects are finalists for $100M U.S. EDA grants
Two Virginia projects — one to make Central Virginia an advanced pharmaceutical manufacturing hub and one to support the transportation and logistics cluster in Southern and Southwest Virginia — are two of 60 finalists for the U.S. Economic Development Administration’s Build Back Better Regional Challenge, which will provide awardees with up to $100 million each. […]
AMPAC expanding Petersburg operation, adding 156 jobs
AMPAC Fine Chemicals plans to grow its Petersburg manufacturing facility, investing $25 million and creating 156 jobs, Gov. Ralph Northam announced Tuesday. AMPAC manufactures active pharmaceutical ingredients (APIs) and is a partner with Richmond-based Phlow Corp., Virginia Commonwealth University’s Medicines for All Institute and nonprofit drugmaker Civica Inc., on a federally funded, $354[...]
Central Va. pharma hub strategic plan released
On Tuesday, the Virginia Commonwealth University College of Engineering announced its strategy to turn Central Virginia into an advanced pharmaceutical manufacturing, research and development hub. The strategic plan aims to foster business and job growth in the Richmond–Petersburg area while also expanding access to medicines. The creation of the plan was funded by a $100,000 […]
Phlow announces national coalition with children’s hospitals
Richmond-based Phlow Corp. announced Thursday the launch of a coalition that will help ensure that children’s hospitals across the country receive key medications. The Virginia Commonwealth University-affiliated Children’s Hospital of Richmond is one of 11 founding hospital members. Children’s Hospital Coalition (CHC) aims to provide certainty in availability and access to medici[...]
$125M pharma manufacturing plant coming to Petersburg
Utah-based pharmaceutical manufacturer Civica Inc. plans to invest $124.5 million to establish its North American manufacturing headquarters operation in Petersburg, creating 186 jobs and manufacturing injectable medicines for the treatment of COVID-19, the governor’s office announced Thursday. A nonprofit generic drug company, Civica was established in 2018 by a group of U.S. health systems[...]
Trump administration chooses RVA pharma startup for $354M COVID-19 contract
Richmond-based drug manufacturing company Phlow Corp., which incorporated this year, announced Tuesday that the Trump administration has awarded it a $354 million, four-year contract to manufacture in the U.S. generic medicines and pharmaceutical ingredients needed to treat COVID-19, creating an American supply chain for medical products that are now made mostly in China and India. […]
